Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
acollaboration, aCooperative, Alfred, alleged, Anesthesia, antigen, anxiety, appeal, Appendix, Arizona, authoritative, Biodesign, budgetary, ceiling, Chairperson, Chardan, CI, Cleveland, cohort, Coleman, conflict, consultantsan, context, copyright, Core, Corium, CRADA, culminated, customer, deferral, detain, dismissed, DropCar, Duke, earliest, EMA, embedded, enable, era, evasion, Farlow, FDIC, formal, gbryostatin, Gergel, geriatric, gpatient, Hanley, Hospitalfor, host, immunotherapy, indefinite, Indiana, injunction, intercept, intoa, invention, Ivan, Jen, jeopardized, Jonathan, Jr, Katzman, Kensington, Lee, Leon, leukemia, Lou, lymphoma, magna, Marwan, Maxim, McKnight, narrowing, Nektar, Neuraptive, neurologist, Neurosurgery, pace, paragraph, Pediatric, Physiology, pioneering, POB, pp, predominantly, prejudice, premier, prospective, proximity, psychiatry, Psychology, qualification, readily, Realm, recapture, reinterpret, renegotiate, renowned, repetitive, resubmit, Rhein, rivastigmine, Rochester, Royal, Ruvo, SAB, Sabbagh, SAP, Schechter, screened, screening, seize, shutdown, slope, spending, succeed, synergistic, synthetic, tacrine, Taiwan, Thal, trend, Tucson, UA, unchanged, undergone, unforeseen, untitled, upcoming, upregulate, USPTO, vol, volunteer, Wei, Wharton, young
Removed:
acceleration, acquired, acquirer, adjustment, administer, anhydrase, applying, array, assist, autism, avoidance, Bachelor, bid, carbonic, Chile, cholesterol, cleared, COD, Concurrently, Consumer, contracted, converted, corrective, Dan, decided, defect, denied, depreciation, desirable, desire, died, disorder, displayed, disturbance, doubt, East, EDI, efficiently, employed, expansion, explored, fifty, FRAXA, Freiman, FXS, gait, generalizing, genetic, Haft, hierarchal, historically, inhibit, Jay, listing, Marissa, merging, mice, mouse, negotiating, NRVI, occurrence, Optimization, optimizing, owed, par, participated, paying, penetration, prosecuting, reappointed, reincorporated, reincorporation, rejected, relinquished, renewal, replaced, resale, Santiago, scientist, selection, shareholder, signatory, SOAR, solvency, SOW, spectrum, speech, Street, style, surrender, thinly, ticker, trafficking, transferred, uncured, undertaken, underway, usable, variable, Watson, whatsoever
Filing tables
Filing exhibits
Neurotrope similar filings
Filing view
External links
Exhibit 32.1
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Neurotrope, Inc., a Nevada corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report for the year ended December 31, 2018 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: March 8, 2019 | /s/ Charles S. Ryan, JD, PhD |
Name: Charles S. Ryan, JD, PhD | |
Title: Chief Executive Officer | |
Principal Executive Officer | |
Dated: March 8, 2019 | /s/ Robert Weinstein |
Name: Robert Weinstein | |
Title: Chief Financial Officer, Executive Vice President, Treasurer and Secretary | |
Principal Financial Officer |